YD Bio Limited (YDES)

YD Bio Statistics

Total Valuation

YD Bio has a market cap or net worth of $1.22 billion. The enterprise value is $1.24 billion.

Market Cap	1.22B
Enterprise Value	1.24B

Important Dates

The last earnings date was Tuesday, September 30, 2025, after market close.

Earnings Date	Sep 30, 2025
Ex-Dividend Date	n/a

Share Statistics

YD Bio has 70.32 million shares outstanding. The number of shares has increased by 4.01% in one year.

Current Share Class	70.32M
Shares Outstanding	70.32M
Shares Change (YoY)	+4.01%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.46%
Owned by Institutions (%)	0.05%
Float	69.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	37.75
Forward PS	n/a
PB Ratio	3.85
P/TBV Ratio	316.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2,420.30
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.18, with a Debt / Equity ratio of 0.00.

Current Ratio	13.18
Quick Ratio	12.91
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,893.69

Financial Efficiency

Return on equity (ROE) is -42.69% and return on invested capital (ROIC) is -27.34%.

Return on Equity (ROE)	-42.69%
Return on Assets (ROA)	-25.43%
Return on Invested Capital (ROIC)	-27.34%
Return on Capital Employed (ROCE)	-22.15%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.14
Inventory Turnover	6.65

Taxes

In the past 12 months, YD Bio has paid $25,080 in taxes.

Income Tax	25,080
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.16
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	49.23
Average Volume (20 Days)	65,758

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, YD Bio had revenue of $510,360 and -$1.41 million in losses. Loss per share was -$1.29.

Revenue	510,360
Gross Profit	155,356
Operating Income	-1.46M
Pretax Income	-1.39M
Net Income	-1.41M
EBITDA	-1.36M
EBIT	-1.46M
Loss Per Share	-$1.29

Balance Sheet

The company has $3.13 million in cash and $22,265 in debt, giving a net cash position of $3.11 million or $0.04 per share.

Cash & Cash Equivalents	3.13M
Total Debt	22,265
Net Cash	3.11M
Net Cash Per Share	$0.04
Equity (Book Value)	6.59M
Book Value Per Share	4.57
Working Capital	3.20M

Cash Flow

In the last 12 months, operating cash flow was -$1.84 million and capital expenditures -$74,914, giving a free cash flow of -$1.91 million.

Operating Cash Flow	-1.84M
Capital Expenditures	-74,914
Free Cash Flow	-1.91M
FCF Per Share	-$0.03

Margins

Gross margin is 30.44%, with operating and profit margins of -286.45% and -276.58%.

Gross Margin	30.44%
Operating Margin	-286.45%
Pretax Margin	-271.67%
Profit Margin	-276.58%
EBITDA Margin	-265.93%
EBIT Margin	-286.45%
FCF Margin	n/a

Dividends & Yields

YD Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.01%
Shareholder Yield	-4.01%
Earnings Yield	-0.11%
FCF Yield	-0.15%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

YD Bio has an Altman Z-Score of 104.61 and a Piotroski F-Score of 1.

Altman Z-Score	104.61
Piotroski F-Score	1